BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3258792)

  • 1. Response of primary human mammary tumor cell cultures to a monoclonal antibody-recombinant ricin A chain immunotoxin.
    Bjorn MJ; Smith HS; Dairkee SH
    Cancer Immunol Immunother; 1988; 26(2):121-4. PubMed ID: 3258792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ
    Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
    Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human corneal epithelial proliferation with breast carcinoma immunotoxin.
    Fulcher S; Foulks GN; Wilkerson M; Cobo LM; Houston LL; Hatchell D
    Cornea; 1993 Sep; 12(5):391-6. PubMed ID: 8306659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.
    Wu YN; Gadina M; Tao-Cheng JH; Youle RJ
    J Cell Biol; 1994 May; 125(4):743-53. PubMed ID: 8188744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
    Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
    J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synovial membrane, liver, and tongue: target organs for a ricin A-chain immunotoxin (ZD0490).
    Westwood FR; Jones DV; Aldridge A
    Toxicol Pathol; 1996; 24(4):477-83. PubMed ID: 8864189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
    Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conjugation of an AQP1-directed immunotoxin in the study of site-directed therapy within the CNS.
    Surash S; Nemeth P; Chakrabarty A; Chumas P
    Childs Nerv Syst; 2011 May; 27(5):811-8. PubMed ID: 21104258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
    Rosenblum MG; Marks JW; Cheung LH
    Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the activity of immunotoxins by analogues of verapamil.
    Pirker R; FitzGerald DJ; Raschack M; Frank Z; Willingham MC; Pastan I
    Cancer Res; 1989 Sep; 49(17):4791-5. PubMed ID: 2788030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.
    Weiner LM; O'Dwyer J; Kitson J; Comis RL; Frankel AE; Bauer RJ; Konrad MS; Groves ES
    Cancer Res; 1989 Jul; 49(14):4062-7. PubMed ID: 2786751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin.
    Xu FJ; Boyer CM; Bae DS; Wu S; Greenwald M; O'Briant K; Yu YH; Mills GB; Bast RC
    Int J Cancer; 1994 Oct; 59(2):242-7. PubMed ID: 7927925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen.
    Derbyshire EJ; de Leij L; Wawrzynczak EJ
    Br J Cancer; 1993 Jun; 67(6):1242-7. PubMed ID: 8390281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.
    Pai LH; Batra JK; FitzGerald DJ; Willingham MC; Pastan I
    Cancer Res; 1992 Jun; 52(11):3189-93. PubMed ID: 1591729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selective cytotoxic effect of an immunotoxin on human erythroid tumor cells].
    Tonevitskiĭ AG; Agapov II; Mechetner EB
    Mol Biol (Mosk); 1991; 25(5):1181-7. PubMed ID: 1753950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.